Portfolio Lab

Iqvia Holdings Inc.

  • Stock
  • Ticker IQV
  • ISIN US46266C1053
  • NYSE

Health care · Biotechnology · USA

$245.82 −1.89%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Iqvia Holdings Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

IQVGlobal equities (VT)

$10,000 grew to $30,720. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −51.5% in 05/2025, measured from the peak in 12/2021. The old peak has not been reached again yet.

1-year return
+13.2%
5-year return p.a.
−1.7%
10-year return p.a.
+11.9%
Volatility p.a.
31.6%
Largest decline
−51.5%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue3,9583,8294,0174,1004,3644,1514,3684,428
Operating income626496506553627514506572
EBITDA929761782839944802798893
Net income437249266331514274256350
Earnings per share2.411.401.541.932.981.611.532.10
Balance sheet
Total assets26,89927,32228,63228,72729,94429,67529,88130,474
Liabilities20,83221,33722,84622,43923,31423,32623,58023,683
Equity6,0675,9775,7786,1606,5036,2216,1716,660
Cash1,7021,7402,0391,8141,9801,9471,9092,249
Long-term debt12,83813,10814,17712,79313,88413,98913,70514,823
Cash flow
Operating cash flow885568443908735618558825
Capital expenditure-164-142-151-136-174-127-198-158
Free cash flow721426292772561491360667

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2021 at +57.5%, weakest 2022 at −27.4%. 7 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
27 Oct 2026$2.10
28 Jul 2026$1.53
5 May 2026$1.61
17 Feb 2026$2.98
28 Oct 2025$1.93
22 Jul 2025$1.54
6 May 2025$1.40
13 Feb 2025$2.41
31 Oct 2024$1.55
22 Jul 2024$1.97
2 May 2024$1.56
15 Feb 2024$2.53

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€37bn
Market cap in trading currency
$40.5bn
Enterprise value
$54.2bn
P/E
29.9
P/S
2.34
P/B
6.08
EV/Sales
3.13
EV/EBITDA
15.8
Earnings yield
3.3%
FCF yield
5.1%

Results (last four quarters)

Revenue
$17.3bn
Gross profit
–
EBITDA
$3.44bn
Net income
$1.39bn
Earnings per share
$8.22
Revenue per share
$105.04
Revenue growth
+8.0%
Earnings growth
+5.7%

Profitability

Gross margin
–
Operating margin
12.8%
Net margin
8.1%
Return on equity
21.7%
Return on assets
4.6%

Balance sheet and cash flow

Cash
$2.42bn
Cash per share
$14.70
Financial debt
$16.1bn
Debt/equity %
241
Current ratio
0.83
Book value per share
$40.41
Operating cash flow
$2.74bn
Free cash flow
$2.08bn

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
165m
Volume
1.23m
Avg. volume 3 months
1.44m
Relative volume
0.8

Price and technicals

Price
$245.82
1 day
−1.9%
52-week high
$279.36
52-week low
$156.66
Distance to 52-week high
−12.0%
Distance to 52-week low
+56.9%
Distance to 50-day line
−7.9%
Distance to 200-day line
+15.9%
RSI (14)
32
Volatility 1M
29.8%

Performance

1 week
−7.3%
1 month
−11.7%
3 months
−5.5%
6 months
+46.4%
YTD
+9.1%
1 year
+13.0%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has IQV performed since 11/2016?

$10,000 grew to $30,720 by 20 Nov 2026, which is +11.9% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is IQV?

Volatility was 31.6% per year, measured on monthly returns. The largest decline from a peak was −51.5%, with the low in 05/2025.

How does IQV compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, IQV returned +11.9% at 31.6%. The correlation of monthly returns was 0.61; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Iqvia Holdings Inc. (IQV): Return and risk | Portfolio Lab